What 9 Analyst Ratings Have To Say About CVS Health
Portfolio Pulse from Benzinga Insights
Analysts have mixed views on CVS Health, with recent ratings showing a majority as indifferent. The average 12-month price target is $62.33, slightly down from previous estimates. CVS Health's financial metrics indicate challenges in profitability and asset utilization, despite strong market capitalization and revenue growth.
September 10, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CVS Health has received mixed analyst ratings, with most analysts being indifferent. The average price target is $62.33, slightly lower than before. Financial metrics show challenges in profitability and asset utilization, despite strong revenue growth.
The article provides a detailed analysis of CVS Health's recent analyst ratings, which are mostly indifferent. The average price target has slightly decreased, indicating a neutral short-term impact. Financial metrics suggest challenges in profitability and asset utilization, which could affect investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100